eLife welcomes 85 new editors in 15 subject areas

Our Board of Reviewing Editors grows to 318 in total, supporting the efficiency of eLife’s unique peer-review process.
Inside eLife

We are delighted to announce the newest members of the eLife Board of Reviewing Editors (BRE), bringing expertise in: Biochemistry, Biophysics and Structural Biology, Cancer Biology, Cell Biology, Computational and Systems Biology, Developmental Biology and Stem Cells, Ecology, Epidemiology and Global Health, Genes and Chromosomes, Genomics and Evolutionary Biology, Human Biology and Medicine, Immunology, Microbiology and Infectious Disease, Neuroscience, and Plant Biology.

The Reviewing Editors are responsible for reviewing articles, at the request of the Senior Editors, and recruiting additional reviewers as needed. Once reviews are in, the participating reviewers consult with one another to finalise their decision and form a consolidated set of comments for the author – this is what sets eLife’s editorial process apart from others.

eLife editors are invited to join eLife by the Editor-in-Chief, after consultation with appropriate Deputy, Senior, and Reviewing Editors. The newest members of the eLife BRE include:

  • Andrés Aguilera, CABIMER, Universidad de Sevilla (Genes and chromosomes)
  • Patricia Bassereau, Institut Curie (Biophysics and structural biology)
  • Philippe I. Bastiaens, Max Planck Institute of Molecular Physiology (Cell biology)
  • Facundo D. Batista, Ragon Institute of MGH, MIT and Harvard (Immunology)
  • James M. Berger, Johns Hopkins University School of Medicine (Biochemistry)
  • Dwight E. Bergles, Johns Hopkins University School of Medicine (Neuroscience)
  • Pamela J. Bjorkman, California Institute of Technology (Biophysics and structural biology)
  • Andrew Brack, UCSF School of Medicine (Developmental biology and stem cells)
  • Neil Burgess, University College London (Neuroscience)
  • Catherine Carr, University of Maryland (Neuroscience)
  • Agnieszka Chacinska, International Institute of Molecular and Cell Biology (Biochemistry)
  • Baron Chanda, University of Wisconsin-Madison (Biophysics and structural biology)
  • László Csanády, Semmelweis University (Biophysics and structural biology)
  • Yang Dan, University of California, Berkeley (Neuroscience)
  • Job Dekker, University of Massachusetts Medical School (Computational and systems biology)
  • Michael L. Dustin, University of Oxford (Immunology)
  • Bruce Edgar, University of Utah (Developmental biology and stem cells)
  • Tõnu Esko, University of Tartu (Human biology and medicine)
  • Neil M. Ferguson, Imperial College London (Epidemiology and global health)
  • Timothy Formosa, The University of Utah (Genes and chromosomes)
  • Fred H. Gage, Salk Institute for Biological Studies (Developmental biology and stem cells)
  • Holger Gerhardt, Max Delbrück Centre for Molecular Medicine (Developmental biology and stem cells)
  • Alison Goate, Icahn School of Medicine at Mount Sinai (Neuroscience)
  • Yukiko Goda, RIKEN (Neuroscience)
  • Michel Goedert, University of Cambridge (Neuroscience)
  • Franz-Ulrich Hartl, Max Planck Institute for Biochemistry (Biochemistry)
  • Edith Heard, Institut Curie (Genes and chromosomes)
  • John Huguenard, Stanford University School of Medicine (Neuroscience)
  • Bavesh D. Kana, University of the Witwatersrand (Microbiology and infectious disease)
  • Lewis E. Kay, University of Toronto (Biophysics and structural biology)
  • Laurent Keller, University of Lausanne (Ecology)
  • Karla Kirkegaard, Stanford University School of Medicine (Microbiology and infectious disease)
  • Elisabeth Knust, Max Planck Institute of Molecular Cell Biology and Genetics (Cell biology)
  • Leonid Kruglyak, Howard Hughes Medical Institute, University of California, Los Angeles (Genes and chromosomes)
  • Tomohiro Kurosaki, Osaka University (Immunology)
  • David Lentink, Stanford University (Ecology)
  • Elena Levashina, Max Planck Institute for Infection Biology (Microbiology and infectious disease)
  • Ross L. Levine, Memorial Sloan Kettering Cancer Center (Cancer biology)
  • Richard S. Lewis, Stanford University School of Medicine (Biophysics and structural biology)
  • Cristina Lo Celso, Imperial College London (Developmental biology and stem cells)
  • Andrei N. Lupas, Max Planck Institute for Developmental Biology (Genomics and evolutionary biology)
  • Andrew J. MacPherson, University Hospital of Bern (Immunology)
  • Jamey Marth, University of California, Santa Barbara (Human biology and medicine)
  • Andreas Martin, University of California, Berkeley (Biochemistry)
  • Carol A. Mason, Columbia University (Neuroscience)
  • Todd McDevitt, Gladstone Institutes (Developmental biology and stem cells)
  • Tâm Mignot, Aix Marseille University (Microbiology and infectious disease)
  • Lisa Monteggia, University of Texas Southwestern Medical Center (Neuroscience)
  • Maureen Murphy, The Wistar Institute (Cancer biology)
  • Klaus-Armin Nave, Max Planck Institute for Experimental Medicine (Neuroscience)
  • Dianne K. Newman, Howard Hughes Medical Institute California Institute of Technology (Microbiology and infectious disease)
  • Lee Niswander, University of Colorado Anschutz Medical Campus (Developmental biology and stem cells)
  • Harry T. Orr, University of Minnesota (Neuroscience)
  • Madhukar Pai, McGill University (Epidemiology and global health)
  • Nipam H. Patel, University of California, Berkeley (Developmental biology and stem cells)
  • Martin Pera, University of Melbourne (Developmental biology and stem cells)
  • George H. Perry, Pennsylvania State University (Ecology)
  • Christine Petit, Institut Pasteur (Neuroscience)
  • Yijun Qi, Tsinghua University (Plant biology)
  • Jeremy F. Reiter, University of California, San Francisco (Cell biology)
  • Margaret S. Robinson, University of Cambridge (Cell biology)
  • Antonis Rokas, Vanderbilt University (Genomics and evolutionary biology)
  • Ranulfo Romo, Universidad Nacional Autónoma de México (Neuroscience)
  • Clifford J. Rosen, Maine Medical Center Research Institute (Human biology and medicine)
  • Nicole Rust, University of Pennsylvania (Neuroscience)
  • Christian Rutz, University of St Andrews (Ecology)
  • Emilio Salinas, Wake Forest School of Medicine (Neuroscience)
  • Bernhard Schmid, University of Zurich (Ecology)
  • Charles E. Schroeder, Columbia University College of Physicians and Surgeons (Neuroscience)
  • Piali Sengupta, Brandeis University (Neuroscience)
  • Ben Sheldon, Department of Zoology, University of Oxford (Ecology)
  • Beth Stevens, Boston Children's Hospital, Harvard Medical School (Neuroscience)
  • Cassidy Sugimoto, Indiana University Bloomington (Computational and systems biology)
  • Nicholas Turk-Browne, Princeton University (Neuroscience)
  • Maarten van Lohuizen, The Netherlands Cancer Institute (Genes and chromosomes)
  • Aleksandra M. Walczak, École Normale Supérieure (Computational and systems biology)
  • Yue Wang, Agency for Science, Technology and Research (Cell biology)
  • Zhi-Yong Wang, Carnegie Institution for Science (Plant biology)
  • Oliver Weichenrieder, Max Planck Institute for Developmental Biology (Genomics and evolutionary biology)
  • Andrew B. West, University of Alabama at Birmingham (Neuroscience)
  • Anne West, Duke University School of Medicine (Neuroscience)
  • Richard M. White, Memorial Sloan Kettering Cancer Center (Cancer biology)
  • Deborah Yelon, University of California, San Diego (Cell biology)
  • Hong Zhang, Institute of Biophysics, Chinese Academy of Sciences (Cell biology)
  • Jian-Min Zhou, Chinese Academy of Sciences (Plant biology)